eConsent provides several means of delivering complex trial information to the trial participant that improves comprehension and engagement. These are some of several benefits that have increased the use of eConsent, and this trend has been accelerated even more by the current COVID-19 pandemic.

eConsent can eliminate the need for physical contact during the consent process, overcoming hurdles such as COVID-19 control measures, site closures, quarantines, travel limitations and more.

In our latest white paper about eConsent we touch upon some of the considerations when implementing eConsent in your clinical trial.


    You must agree before submitting.

    For more information on how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

    Input this code: captcha